Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
531 questions in 102 reviews · Gynaecology and Fertility
current versionsNo studies 531 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Gel agents vs hydroflotation agents used Clinical pregnancy rate · women during gynaecological surgery Fluid and pharmacological agents for adhesion prevention after gynaecological surgery (2020) · Cochrane | no estimate extracted | NR | No studies |
Gel agents vs hydroflotation agents used Adverse events · women during gynaecological surgery Fluid and pharmacological agents for adhesion prevention after gynaecological surgery (2020) · Cochrane | no estimate extracted | NR | No studies |
Steroids (any route) vs no steroids (or placebo) Pelvic pain · women after gynaecological surgery Fluid and pharmacological agents for adhesion prevention after gynaecological surgery (2020) · Cochrane | no estimate extracted | NR | No studies |
Steroids (any route) vs no steroids (or placebo) Incidence of adhesions at second‐look laparoscopy · women after gynaecological surgery Fluid and pharmacological agents for adhesion prevention after gynaecological surgery (2020) · Cochrane | no estimate extracted | NR | No studies |
Steroids (any route) vs no steroids (or placebo) Mean adhesion score at second‐look laparoscopy · women after gynaecological surgery Fluid and pharmacological agents for adhesion prevention after gynaecological surgery (2020) · Cochrane | no estimate extracted | NR | No studies |
Steroids (any route) vs no steroids (or placebo) Adverse events · women after gynaecological surgery Fluid and pharmacological agents for adhesion prevention after gynaecological surgery (2020) · Cochrane | no estimate extracted | NR | No studies |
Hydroflotation agents vs no hydroflotation agents (or placebo) Adverse events · women undergoing gynaecological surgery Fluid and pharmacological agents for adhesion prevention after gynaecological surgery (2020) · Cochrane | no estimate extracted | NR | No studies |
Gel agents vs no gel agents (or placebo) Pelvic pain · women undergoing gynaecological surgery Fluid and pharmacological agents for adhesion prevention after gynaecological surgery (2020) · Cochrane | no estimate extracted | NR | No studies |
Gel agents vs no gel agents (or placebo) Live birth rate · women undergoing gynaecological surgery Fluid and pharmacological agents for adhesion prevention after gynaecological surgery (2020) · Cochrane | no estimate extracted | NR | No studies |
IUI in a stimulated cycle vs TI or expectant management Ovarian hyperstimulation syndrome rate per woman · participants with unexplained subfertility Intra‐uterine insemination for unexplained subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
IUI in a natural cycle vs TI or expectant management Ovarian hyperstimulation syndrome rate per woman ‐ not reported · participants with unexplained subfertility Intra‐uterine insemination for unexplained subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
IUI in a stimulated cycle vs IUI Ovarian hyperstimulation syndrome rate per woman ‐ not measured · participants with unexplained subfertility Intra‐uterine insemination for unexplained subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
IUI in a natural cycle vs TI or expectant management Ovarian hyperstimulation syndrome rate per woman ‐ not reported · participants with unexplained subfertility Intra‐uterine insemination for unexplained subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
Tubal surgery vs no surgery Live birth rate · tubal disease in women due to undergo in vitro fertilisation Surgical treatment for tubal disease in women due to undergo in vitro fertilisation (2020) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic proximal tubal occlusion vs laparoscopic salpingectomy Live birth rate · tubal disease in women due to undergo in vitro fertilisation Surgical treatment for tubal disease in women due to undergo in vitro fertilisation (2020) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic proximal tubal occlusion vs laparoscopic salpingectomy Surgical complication rate ‐ wound infection · tubal disease in women due to undergo in vitro fertilisation Surgical treatment for tubal disease in women due to undergo in vitro fertilisation (2020) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic proximal tubal occlusion vs laparoscopic salpingectomy Surgical complication rate ‐ pelvic infection · tubal disease in women due to undergo in vitro fertilisation Surgical treatment for tubal disease in women due to undergo in vitro fertilisation (2020) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic proximal tubal occlusion vs laparoscopic salpingectomy Clinical pregnancy rate · tubal disease in women due to undergo in vitro fertilisation Surgical treatment for tubal disease in women due to undergo in vitro fertilisation (2020) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic proximal tubal occlusion vs laparoscopic salpingectomy Miscarriage rate · tubal disease in women due to undergo in vitro fertilisation Surgical treatment for tubal disease in women due to undergo in vitro fertilisation (2020) · Cochrane | no estimate extracted | NR | No studies |
Laparoscopic proximal tubal occlusion vs laparoscopic salpingectomy Ectopic pregnancy rate · tubal disease in women due to undergo in vitro fertilisation Surgical treatment for tubal disease in women due to undergo in vitro fertilisation (2020) · Cochrane | no estimate extracted | NR | No studies |
Transvaginal aspiration of hydrosalpingeal fluid vs laparoscopic salpingectomy Live birth rate · tubal disease in women due to undergo in vitro fertilisation Surgical treatment for tubal disease in women due to undergo in vitro fertilisation (2020) · Cochrane | no estimate extracted | NR | No studies |
Tubal surgery vs no surgery Surgical complication rate ‐ conversion to laparotomy · tubal disease in women due to undergo in vitro fertilisation Surgical treatment for tubal disease in women due to undergo in vitro fertilisation (2020) · Cochrane | no estimate extracted | NR | No studies |
Tubal surgery vs no surgery Surgical complication rate ‐ pelvic infection · tubal disease in women due to undergo in vitro fertilisation Surgical treatment for tubal disease in women due to undergo in vitro fertilisation (2020) · Cochrane | no estimate extracted | NR | No studies |
Tubal surgery vs no surgery Clinical pregnancy rate · tubal disease in women due to undergo in vitro fertilisation Surgical treatment for tubal disease in women due to undergo in vitro fertilisation (2020) · Cochrane | no estimate extracted | NR | No studies |
Tubal surgery vs no surgery Miscarriage rate · tubal disease in women due to undergo in vitro fertilisation Surgical treatment for tubal disease in women due to undergo in vitro fertilisation (2020) · Cochrane | no estimate extracted | NR | No studies |
Tubal surgery vs no surgery Ectopic pregnancy rate · tubal disease in women due to undergo in vitro fertilisation Surgical treatment for tubal disease in women due to undergo in vitro fertilisation (2020) · Cochrane | no estimate extracted | NR | No studies |
LNG‐IUS vs hysterectomy Adverse events · heavy menstrual bleeding Progestogen‐releasing intrauterine systems for heavy menstrual bleeding (2020) · Cochrane | no estimate extracted | NR | No studies |
LNG‐IUS vs any other medical treatment Cost · heavy menstrual bleeding Progestogen‐releasing intrauterine systems for heavy menstrual bleeding (2020) · Cochrane | no estimate extracted | NR | No studies |
Presurgical medical therapy vs placebo or no medical therapy Pain (continuous) Pelvic pain ≤ 12 months · women having endometriosis surgery Pre‐ and postsurgical medical therapy for endometriosis surgery (2020) · Cochrane | no estimate extracted | NR | No studies |
Presurgical medical therapy vs postsurgical medical therapy Pain (continuous) Pelvic pain ≤ 12 months · women having endometriosis surgery Pre‐ and postsurgical medical therapy for endometriosis surgery (2020) · Cochrane | no estimate extracted | NR | No studies |
Presurgical medical therapy vs postsurgical medical therapy Disease recurrence at 12 months –total (AFS score) · women having endometriosis surgery Pre‐ and postsurgical medical therapy for endometriosis surgery (2020) · Cochrane | no estimate extracted | NR | No studies |
Presurgical medical therapy vs postsurgical medical therapy Disease recurrence ≤ 12 months (dichotomous) · women having endometriosis surgery Pre‐ and postsurgical medical therapy for endometriosis surgery (2020) · Cochrane | no estimate extracted | NR | No studies |
Presurgical medical therapy vs placebo or no medical therapy Disease recurrence ≤ 12 months (dichotomous) · women having endometriosis surgery Pre‐ and postsurgical medical therapy for endometriosis surgery (2020) · Cochrane | no estimate extracted | NR | No studies |
Tubal flushing with water‐soluble contrast media (WSCM) vs no intervention Haemorrhage · women with subfertility Tubal flushing for subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
Tubal flushing with water‐soluble contrast media (WSCM) vs no intervention Long‐term complications · women with subfertility Tubal flushing for subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
Tubal flushing with oil‐soluble contrast media (OSCM) vs no intervention Intravasation · women with subfertility Tubal flushing for subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
Tubal flushing with oil‐soluble contrast media (OSCM) vs no intervention Infection · women with subfertility Tubal flushing for subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
Tubal flushing with oil‐soluble contrast media (OSCM) vs no intervention Haemorrhage · women with subfertility Tubal flushing for subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
Tubal flushing with oil‐soluble contrast media (OSCM) vs no intervention Long‐term complications · women with subfertility Tubal flushing for subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
Tubal flushing with water‐soluble contrast media (WSCM) vs no intervention Intravasation · women with subfertility Tubal flushing for subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
Myomectomy vs no treatment Live birth rate · fibroids for infertility Surgical treatment of fibroids for subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
Myomectomy vs no treatment Caesarean section rate · fibroids for infertility Surgical treatment of fibroids for subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
Myomectomy vs no treatment Preterm delivery rate · fibroids for infertility Surgical treatment of fibroids for subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
Monopolar resectoscope vs bipolar resectoscope Preterm delivery rate · hysteroscopic myomectomy for infertility Surgical treatment of fibroids for subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
Monopolar resectoscope vs bipolar resectoscope Caesarean section rate · hysteroscopic myomectomy for infertility Surgical treatment of fibroids for subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
Myomectomy vs no treatment Ongoing pregnancy rate · fibroids for infertility Surgical treatment of fibroids for subfertility (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Outcomes per woman · couples with an in vitro fertilisation indication Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Ongoing pregnancy · couples with an in vitro fertilisation indication Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation (2020) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Outcomes per woman · couples with an in vitro fertilisation indication Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation (2020) · Cochrane | no estimate extracted | NR | No studies |
Metformin vs metformin combined with oral contraceptive pill (OCP) Improved menstrual pattern · adult women with PCOS Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in… (2020) · Cochrane | no estimate extracted | NR | No studies |